Question:
Are blood derivatives such as albumin infused for therapeutic treatment of liver failure or diseases such as cirrhosis billed as a biological by the pharmacy?
Answer:
Yes, understand that blood derivatives such as albumin infused for therapeutic treatment of liver failure or diseases such as cirrhosis or nephrotic syndrome resulting in hypoalbuminemia are billed as a biological by the pharmacy, and the administration of that substance is reported as drug administration, not blood transfusion.